NEUREN PHARMACEUTICALS LIMITED |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 20.27 AUD | -6.33% |
|
-2.12% | -18.82% |
| 28/05 | Transcript : Neuren Pharmaceuticals Limited - Shareholder/Analyst Call | |
| 27/05 | Neuren Phase 2 Trial Shows Significant Improvements in Pitt Hopkins Syndrome | CI |
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
End-of-day quotes
End-of-day quotes
Sector Other Pharmaceuticals
| Capi. | Sales growth | Profitability | Finances | EV / Sales | P/E ratio | |
|---|---|---|---|---|---|---|
| 183.48Cr | ||||||
| 74TCr | ||||||
| 60TCr | ||||||
| 35TCr | ||||||
| 32TCr | ||||||
| 28TCr |
